Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cance...

Vrdoljak Eduard, Marschner N., Zielinski Christoph Carl, Gligorov Joseph, Cortes Javier, Puglisi Fabio, Aapro Matti S., Fallowfield Lesley J., Fontana Andrea, Inbar Moshe Josef, Kahán Zsuzsanna, Welt Anja, Lévy Christelle, Brain Étienne G.C, Pivot Xavier B.
2016